Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)

NCT03851445 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT03851445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03851445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 6, 2019
Completion date
January 28, 2029
Enrollment
10,000 (estimated)
Sites
1,229

Conditions

As the registry lists them; a condition with its own page is linked.

previously treated non-small cell lung cancer